Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F19EQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,370
Award facts
- Contract value 100% obligated
- $67,369.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $67,369.99 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally in support of military healthcare programs. The DLA utilizes this comprehensive contract vehicle to procure critical medical commodities across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Dupixent is a specialty biologic medication used for treating moderate-to-severe eczema, asthma, and other inflammatory conditions, reflecting the company's role in delivering specialized pharmaceuticals to federal medical supply chains.
Quick answers
Who was awarded contract SPE2DR26F19EQ?
SPE2DR26F19EQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F19EQ worth?
The government has obligated $67,370 on SPE2DR26F19EQ.
Is contract SPE2DR26F19EQ an order under another contract?
Yes. SPE2DR26F19EQ is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F19EQ competed?
The extent of competition for SPE2DR26F19EQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award